Resonant Capital Advisors LLC raised its holdings in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 10.6% in the 2nd quarter, Holdings Channel.com reports. The fund owned 2,146 shares of the insurance provider’s stock after buying an additional 205 shares during the period. Resonant Capital Advisors LLC’s holdings in Allstate were worth $434,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in ALL. Arlington Trust Co LLC grew its position in Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares in the last quarter. Hughes Financial Services LLC bought a new stake in Allstate during the 1st quarter worth about $28,000. Caitong International Asset Management Co. Ltd lifted its position in Allstate by 315.0% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after buying an additional 126 shares in the last quarter. Hilltop National Bank acquired a new position in shares of Allstate during the 2nd quarter worth about $34,000. Finally, Meeder Asset Management Inc. grew its holdings in shares of Allstate by 113.8% in the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 99 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Down 0.1%
ALL opened at $192.99 on Tuesday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $203.99 and its 200 day simple moving average is $201.13. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70. The stock has a market cap of $50.85 billion, a PE ratio of 9.07, a price-to-earnings-growth ratio of 0.70 and a beta of 0.38.
Analyst Ratings Changes
Several analysts recently issued reports on ALL shares. Evercore ISI set a $233.00 target price on Allstate and gave the stock an “in-line” rating in a report on Wednesday, October 1st. Keefe, Bruyette & Woods upped their price objective on Allstate from $237.00 to $246.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 6th. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a report on Wednesday, October 8th. Citigroup upgraded shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. Finally, Morgan Stanley upped their price target on shares of Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $234.27.
View Our Latest Analysis on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- What is the Euro STOXX 50 Index?
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- What is a support level?
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- The 3 Best Fintech Stocks to Buy Now
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
